Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
67.09
-0.04 (-0.06%)
May 31, 2024, 4:00 PM EDT - Market closed
Axonics Employees
Axonics had 797 employees on December 31, 2023. The number of employees increased by 187 or 30.66% compared to the previous year.
Employees
797
Change (1Y)
187
Growth (1Y)
30.66%
Revenue / Employee
$485,744
Profits / Employee
-$20,015
Market Cap
3.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 797 | 187 | 30.66% |
Dec 31, 2022 | 610 | 93 | 17.99% |
Dec 31, 2021 | 517 | 101 | 24.28% |
Dec 31, 2020 | 416 | 114 | 37.75% |
Dec 31, 2019 | 302 | 215 | 247.13% |
Dec 31, 2018 | 87 | 15 | 20.83% |
Dec 31, 2017 | 72 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Surgery Partners | 13,500 |
Envista Holdings | 12,800 |
Tandem Diabetes Care | 2,400 |
Guardant Health | 1,779 |
Ultragenyx Pharmaceutical | 1,276 |
Alvotech | 1,026 |
PROCEPT BioRobotics | 626 |
Axsome Therapeutics | 545 |
AXNX News
- 17 days ago - Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia - Business Wire
- 4 weeks ago - Axonics Reports First Quarter 2024 Financial Results - Business Wire
- 5 weeks ago - Boston Scientific Announces Results for First Quarter 2024 - PRNewsWire
- 2 months ago - FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal - Reuters
- 2 months ago - Axonics Stockholders Approve Merger Agreement with Boston Scientific - Business Wire
- 2 months ago - Axonics Provides Update on Inter Partes Review Proceedings - Business Wire
- 2 months ago - Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System - Business Wire
- 3 months ago - Axonics Responds to ITC Action by Medtronic - Business Wire